Prevention and Treatment of Osteoporosis in the High-Risk Patient: A Clinician's GuideCyrus Cooper, Stephen H. Gehlbach, Robert Lindsay CRC Press, 2005 M01 25 - 128 páginas The outcome of recent clinical trials in osteoporosis was the impetus for this volume. In these studies of two bisphosphonates, an interaction between bone mineral density (BMD) and the treatment effect was seen, such that these agents appeared to lose their effect as BMD increased. To practitioners this is counter-intuitive. Why should treatment w |
Contenido
1 Perspectives on the problem | 1 |
2 Epidemiology | 11 |
3 Pathophysiology of osteoporosis | 25 |
4 Risk stratification | 40 |
5 The treatment of postmenopausal osteoporosis | 53 |
6 Economic aspects of osteoporosis | 78 |
7 Strategies for prevention | 100 |
| 116 | |
Otras ediciones - Ver todas
Prevention and Treatment of Osteoporosis in the High-Risk Patient: A ... Cyrus Cooper,Stephen H. Gehlbach,Robert Lindsay Vista previa limitada - 2005 |
Prevention and Treatment of Osteoporosis in the High-Risk Patient: A ... Cyrus Cooper,Stephen H. Gehlbach,Robert Lindsay Sin vista previa disponible - 2005 |
Términos y frases comunes
activity adult alendronate analysis appear approach assessment associated benefit bisphosphonates bone density bone loss bone mass bone mineral density breast calcium cancer changes clinical collagen compared controlled Cooper cost cost-effective decrease determine disease early effect elderly estimated estrogen et al evidence exercise factors falls Figure forearm fracture risk fragility fractures function given greater Group hip fracture hormone identified important incidence increase indicate individuals Intern intervention less lifetime major mean measurement Melton models nonvertebral occur older osteoblast Osteoporos Int osteoporotic fractures outcomes patients population postmenopausal osteoporosis postmenopausal women predict prevalence prevention probability raloxifene randomized range rates recent reduce relative replacement resorption risedronate risk factors risk of fracture risk of hip showed shown significant smoking spine strategies strength suggest supplementation T-score Table therapy treatment trial vertebral fractures vitamin weight